AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein
(Q28138445)
scientific article (publication date: December 2000)
scientific article (publication date: December 2000)
Language:
Current Data About
AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein
| (P31) |
(Q13442814)
|
||||||||||||
| (P304) |
3939-47
|
||||||||||||
| (P407) |
(Q1860)
|
||||||||||||
| (P433) |
12
|
||||||||||||
| (P478) |
96
|
||||||||||||
| (P577) |
Friday, December 1, 2000
|
||||||||||||
| (P921) |
(Q29496)
|
||||||||||||
| (P1433) |
(Q885070)
|
||||||||||||
| (P1476) |
"AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein" (language: en)
|
||||||||||||
| (P2093) |
A Melnick
G W Carlile
M J McConnell
A Polinger
S W Hiebert
J D Licht
|